Evidence map›Paper›PMID 35475873›Full record

ArticleJornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia2022

Country-specific lockdown measures in response to the COVID-19 pandemic and its impact on tuberculosis control: a global study.

Giovanni Battista Migliori, Pei Min Thong, Jan-Willem Alffenaar, Justin Denholm, Marina Tadolini, Fatma Alyaquobi, Seif Al-Abri, François-Xavier Blanc, Danilo Buonsenso, Jeremiah Chakaya and 22 more

Open access · diamondAbstract read
In one paragraph

Article in Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 30 citations in OpenAlex.

  1. Pooled it
  2. Spatial and epidemiological mapping of tuberculosis on an Amazon island: effect of the COVID-19 pandemic.Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas · 2026
    Article
  3. Article
  4. Article
  5. Impact of COVID-19 on diagnosis of tuberculosis and tuberculosis infection in South America, Asia, and Africa.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2023
    Article
  11. Outcomes of TB contact tracing and predictors of success: a 10-year retrospective cohort analysis in Birmingham, UK.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2023
    Article
  12. Article
  13. Meeting of two pandemics in prison: a challenging event in a challenging environment.The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease · 2023
    Article
  14. Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network study.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2023
    Article
  15. Review
  16. Review
  17. Article
  18. Effects of COVID-19 on tuberculosis control: past, present, and future.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2022
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors at 20 institutions in 18 countries.

Giovanni Battista Migliori. Istituti Clinici Scientifici Maugeri - IRCCS - Tradate, Italia.ORCID 0000-0002-2597-574X
Pei Min Thong. National University of Singapore, Yong Loo Lin School of Medicine, Singapore, Singapore.ORCID 0000-0002-6928-8626
Jan-Willem Alffenaar. The University of Sydney, Pharmacy School, Sydney (NSW) Australia.ORCID 0000-0001-6703-0288
Justin Denholm. Melbourne Health Victorian Tuberculosis Program, Melbourne (VIC) Australia.ORCID 0000-0002-9214-6431
Marina Tadolini. Infectious Diseases Unit, Istituti Clinici Scientifici Maugeri - IRCCS - Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola, Bologna, Italia.ORCID 0000-0002-1005-7532
Fatma Alyaquobi. TB and Acute Respiratory Diseases Section, Department of Communicable Diseases, Directorate General of Disease Surveillance and Control, National TB Programme, MoH Oman, Muscat, Sultanate of Oman.ORCID 0000-0002-3517-6183
Seif Al-Abri. Directorate General for Disease Surveillance and Control, MoH Oman, Muscat, Sultanate of Oman.ORCID 0000-0002-2669-6814
François-Xavier Blanc. Nantes Université, CHU Nantes, Service de Pneumologie, L'Institut du Thorax, Nantes, France.ORCID 0000-0001-7644-2188
Danilo Buonsenso. Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli - IRCCS - Roma, Italia.ORCID 0000-0001-8567-2639
Jeremiah Chakaya. Department of Medicine, Dermatology and Therapeutics, Kenyatta University, Nairobi, Kenya.ORCID 0000-0002-3229-2429
Jin-Gun Cho. The University of Sidney at Westmead Hospital, Sydney (NSW) Australia.ORCID 0000-0002-0735-4691
Luigi Ruffo Codecasa. TB Reference Centre of Villa Marelli Institute, Niguarda Hospital, Milano, Italia.ORCID 0000-0001-6825-2050
Edvardas Danila. Vilnius University Hospital Santaros Kilinkos, Vilinius, Lithuania.ORCID 0000-0003-2726-1991
Raquel Duarte. National Reference Centre for MDR-TB, Serviço de Pneumologia, Centro Hospitalar de Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal e Departamento de Ciências da Saúde Pública e Forenses, e Educação Médica, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.ORCID 0000-0003-2257-3099
Rada Dukpa. National TB Control Program, Ministry of Health, Timbu, Bhutan.ORCID 0000-0002-0661-309X
José-María García-García. Programa Integrado de Investigación en Tuberculosis - PII-TB - Sociedad Española de Neumología y Cirugía Torácica - SEPAR - Barcelona, España.ORCID 0000-0002-2809-6230
Gina Gualano. Istituto Nazionale per le Malattie Infettive "Lazzaro Spallanzani" - INMI - IRCCS, Roma, Italia.ORCID 0000-0001-6149-0005
Xhevat Kurhasani. UBT - Higher Education Institution, Prishtina, Kosovo.ORCID 0000-0001-6074-9740
Katerina Manika. Pulmonary Department, Aristotle University of Thessaloniki, "G. Papanikolaou" Hospital, Thessaloniki, Greece.ORCID 0000-0001-9474-0293
Fernanda Carvalho de Queiroz Mello. Instituto de Doenças do Tórax, Faculdade de Medicina, Universidade Federal do Rio de Janeiro - UFRJ - Rio de Janeiro (RJ) Brasil.ORCID 0000-0003-3250-6738
Kristin Pahl. Clinton Health Access Initiative, Phnom Penh, Cambodia.ORCID 0000-0001-9799-8820
Adrian Rendon. Centro de Investigación, Prevención y Tratamiento de Infecciones Respiratorias -CIPTIR - Hospital Universitario de Monterrey, Universidad Autónoma de Nuevo León, Monterrey, México.ORCID 0000-0001-8973-4024
Giovanni Sotgiu. Clinical Epidemiology and Medical Statistics Unit, Department of Medical, Surgical and Experimental Sciences, University of Sassari, Sassari, Italy.ORCID 0000-0002-1600-4474
Mahamadou Bassirou Souleymane. Damien Foundation, Niamey, Niger.ORCID 0000-0002-9645-1994
Tania A Thomas. Division of Infectious Diseases and International Health, University of Virginia, Charlottesville (VA) USA.ORCID 0000-0002-3929-6369
Simon Tiberi. Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.ORCID 0000-0001-9424-6551
Heinke Kunst. Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.ORCID 0000-0002-0380-1116
Zarir F Udwadia. P.D. Hinduja National Hospital and Medical Research Centre, Mumbai, India.ORCID 0000-0002-1830-3259
Delia Goletti. Istituto Nazionale per le Malattie Infettive "Lazzaro Spallanzani" - INMI - IRCCS, Roma, Italia.ORCID 0000-0001-8360-4376
Rosella Centis. Istituti Clinici Scientifici Maugeri - IRCCS - Tradate, Italia.ORCID 0000-0002-8551-3598
Lia D'Ambrosio. Public Health Consulting Group, Lugano, Switzerland.ORCID 0000-0002-7000-5777
Denise Rossato Silva. Faculdade de Medicina, Universidade Federal do Rio Grande do Sul - UFRGS- Porto Alegre, Brasil.ORCID 0000-0003-0230-2734
Istituti Clinici Scientifici Maugeri · ITIstituto Nazionale per le Malattie Infettive Lazzaro Spallanzani · ITQueen Mary University of London · GBAgostino Gemelli University Polyclinic · ITAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · ITCentro Hospitalar de Vila Nova de Gaia · PTClinton Health Access Initiative · USDamien Foundation · BDDirectorate General of Health Services · BDG. Papanikolaou General Hospital · GRInstitut du Thorax · FRIRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola · ITLiverpool School of Tropical Medicine · GBMinistry of Health · BBNational University of Singapore · SGNew South Wales Institute of Psychiatry · AUOman Medical College · OMP. D. Hinduja Hospital and Medical Research Centre · INPeter Doherty Institute · AUSociedad Española de Neumología y Cirugía Torácica · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study was to describe country-specific lockdown measures and tuberculosis indicators collected during the first year of the COVID-19 pandemic. Data on lockdown/social restrictions (compulsory face masks and hand hygiene; international and local travel restrictions; restrictions to family visits, and school closures) were collected from 24 countries spanning five continents. The majority of the countries implemented multiple lockdowns with partial or full reopening. There was an overall decrease in active tuberculosis, drug-resistant tuberculosis, and latent tuberculosis cases. Although national lockdowns were effective in containing COVID-19 cases, several indicators of tuberculosis were affected during the pandemic.

Indexed as

COVID-19Influenza, HumanTuberculosisCommunicable Disease ControlHumansPandemics

Identifiers

PMID35475873
PMCPMC9064628
OpenAlexW4226017525

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.